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7 studies demonstrated no statistically
significant difference in arterial graft
occlusion (RR, 1.01; 95% CI, 0.63–
1.60; P ¼ .98; P for heterogeneity
¼ .16) between OPCAB and
CABG-CPB but a statistically signifi-
cant increase in venous graft occlu-
sion (RR, 1.29; 95% CI, 1.08–1.54;
P ¼ .006; P for heterogeneity ¼
.98; Figure 1, A)1,3-7 and overall graft
occlusion (RR, 1.29; 95% CI, 1.00
[1.0028]–1.42; P ¼ .05 [.0465];
P for heterogeneity ¼ .27) with OP-
CAB relative to CABG-CPB in the
fixed-effects model. Two of the 7
studies stated 3-month graft patency,
whereas the remaining 5 studies re-
ported 1-year patency. In a sensitiv-
ity analysis, pooled analysis of the 5
studies reporting 1-year graft pa-
tency demonstrated no statistically
significant difference in arterial graft
occlusion (RR, 0.98; 95% CI, 0.58–
1.68; P ¼ .95; P for heterogeneity
¼ .36) and overall graft occlusion
(RR, 1.16; 95% CI, 0.97–1.40; P ¼
.11; P for heterogeneity ¼ .83) be-
tween OPCAB and CABG-CPB but
a statistically significant increase in
venous graft occlusion (RR, 1.27;
95% CI, 1.06–1.53; P ¼ .01; P for
heterogeneity ¼ .94; Figure 1, B)1,5-7
with OPCAB relative to CABG-
CPB in the fixed-effect model.
The results of our analysis suggest
that OPCAB may attenuate venous
graft patency over CABG-CPB. Four
of the 5 studies included in the sensi-
tivity analysis, however, had merely
1-year follow-up duration as con-
trasted with 7-year follow-up in the
study by Angelini and coworkers.1
Further long-term follow-up results
of randomized controlled trials are
needed to confirm our results.
Hisato Takagi, MD, PhD
Takuya Umemoto, MD, PhD
Shizuoka Medical Center
Department of Cardiovascular
Surgery
Shizuoka, Japan
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Letters to the Editor
The JournReply to the Editor:
In this issue, Takagi and Umemoto1
report a meta-analysis of patency after
coronary artery bypass (CABG) and
off-pump CABG (OPCAB) that we
and others declined to conduct.2,3 We
have 4 comments on the appropriate-
ness of both their revised and original
analyses.4
The authors make the mistake that
we described in our article3—that is,
they assumed statistical independence
of multiple grafts in the same patients.
We reiterate that this ‘‘could seriously
undermine statistical inferences.’’3 In
our own primary patency analysis, ig-
noring the dependency between grafts
within patients would have narrowed
the confidence interval by 40%.
Underestimating the standard errors
by this amount would make all of theiral of Thoracic and Cardiovascular Surgpooled estimates not statistically sig-
nificant.
Meta-analysts should write a proto-
col in advance,5 including specifying
the planned analyses. Can Takagi and
Umemoto confirm that the subgroup
analysis by different conduit type
was prespecified? In the Beating Heart
Against Cardioplegic Arrest Study
(BHACAS) follow-up, the 2 groups
had very similar overall occlusion
rates, but the proportions of vein and
arterial grafts occluded in the OPCAB
compared with the CABG group hap-
pened to be in the directions observed
in the original meta-analysis.4 We had
no prior hypothesis that veins should
be more at risk of occlusion with OP-
CAB and concluded that our nonsig-
nificant findings arose by chance. Did
Takagi and Umemoto report the sub-
group analyses because it showed sta-
tistical significance, without a prior
intention to do so?
Although updating a meta-analysis
is always worthwhile, one should not
expect the addition of a single new re-
sult to overturn a previous conclusion
unless the new trial contributes an
overwhelming amount of new infor-
mation (depicted by the size of
a ‘‘blob’’ in a forest plot) or a substan-
tially different estimate (which might
cause concern about heterogeneity).
Neither was the case here.
Inspection of the blobs does, how-
ever, show that one trial contributes
most of the statistical weight.6 Interest-
ingly, the PRAGUE-4 trial reported pa-
tency findings for a similar number of
patients (255) as the BHACAS trials
(199), highlighting that the large weight
is due to a high rate of overall occlusion
(45%) compared with the other trials
(7%–17%). Meta-analysts need to
judge whether it makes sense to pool
data.5 We question whether the
PRAGUE trial should be pooled with
the others, even in the absence of statis-
tical heterogeneity and without obvious
major design differences between stud-
ies. Moreover, there are other important
sources of heterogeneity between trials,ery c Volume 138, Number 3 793
Letters to the Editorsuch as duration of follow-up and sus-
ceptibility to attrition bias.
We conclude that there is no current
evidence that the patency rates are sta-
tistically significantly different for OP-
CAB and CABG. The pooled point
estimate is unaffected by the flawed
data analysis, so the risk of a vein graft
occlusion using the OPCAB technique
may bez25% higher. However, even
if future data confirm that the risk is
higher, the best answer to the question
‘‘Dare we perform OPCAB. to
merely improve [these] selected clini-
cal and resource outcomes?’’4 is pro-
vided by analyses of outcomes that
are more relevant to patients and less
susceptible to attrition (survival free
from major adverse cardiac-related
events and health-related quality ofNotices of Correction
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